Suwon, South Korea

Neurotech Pharmaceuticals Co., Ltd.

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 25.0


Forward Citations = 21

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Byoung Joo Gwag (5 out of 9 patents)

silverMedal Young Ae Lee (4 out of 10 patents)

bronzeMedal Bo Rum Ryu (3 out of 6 patents)

4.  Ho Sang Moon (3 out of 7 patents)

5.  Sung Hwa Yoon (3 out of 6 patents)

6.  Sung-Ig Cho (2 out of 2 patents)

7.  Byoung-Joo Gwag (2 out of 4 patents)

8.  Jae-Young Cho (2 out of 2 patents)

9.  Young-Ae Lee (2 out of 4 patents)

10.  Han-Yeol Byun (2 out of 2 patents)

11.  Ki-Baik Hahm (2 out of 2 patents)

12.  Young-Bae Kwon (2 out of 2 patents)

13.  Doo-Soon Lim (2 out of 2 patents)

14.  Jin-Hwan Lee (2 out of 2 patents)

15.  Bok-Seon Yoon (2 out of 2 patents)


8 patents:

Company Overview
Neurotech Pharmaceuticals Co., Ltd. is a leading biopharmaceutical company specializing in the development of innovative drug therapies for neurological disorders. With a focus on research and development, Neurotech is committed to improving the lives of patients through cutting-edge treatments. Our team of experts is dedicated to advancing the field of neurology and bringing hope to those suffering from debilitating conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#33 in Suwon

#1,307 in South Korea

Suwon, KR
Suwon, South Korea
Forward Citations = 21

32 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neurotech Pharmaceuticals Co., Ltd.. Retrieved from https://idiyas.com/company/neurotech-pharmaceuticals-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…